Page 21 - MDA SCATE 2023 Programme Book

SPEAKER PROFILE (DAY 2)

Dr. Luqman Bin Ibrahim
MBBS (IIUM), MMed Internal Medicine (UM),
Subspecialty training in endocrinology (KKM)

Dr Luqman is an accredited specialist registered with the Malaysian Medical Council and
National Specialist Register, Malaysia. He graduated with MBBS from the International
Islamic University Malaysia. He pursued his specialty training and obtained MMed in
Internal Medicine from the University of Malaya. He then further obtained his subspecialty
training in endocrinology from the Ministry of Health Malaysia.

Dr Luqman was a Trainee Lecturer and Medical Officer at the Faculty of Medicine in
University of Malaya. In 2012, he became a Senior Lecturer and Clinical Specialist at University
of Malaya. In 2019, he led the Diabetes Care Unit at University Malaya Medical Center.
Dr Luqman is currently a Consultant Endocrinologist and Physician of the Diabetes Care
Unit at the Regency Specialist Hospital, Johor Bahru. He is an active member of the
Malaysian Endocrine and Metabolic Society (MEMS), Malaysian Diabetes Educators Society
(MDES) and Malaysian Osteoporosis Society (MOS). His areas of expertise include Type 1 and
Type 2 diabetes, insulin pump and continuous glucose monitoring, endocrine disorders,
bone and metabolic disorders.

Lecture : Impact of COVID-19 on Patients with Endocrine
Disorders
In late 2019 and early 2020, the world saw the emergence of a novel coronavirus infection,
dubbed the COVID19, and healthcare resources in most countries rapidly became
overwhelmed dealing with this infection. It was soon discovered that people with diabetes
are especially at risk of a more severe infection and death from COVID19.

In this lecture, we will review the impact of COVID19 infection, as well as the impacts of
lockdowns, COVID19 treatment, and COVID19 vaccinations on people with diabetes and
other endocrine disorders.

Importantly, COVID19 also exposed social inequalities and the weaknesses in many healthcare
systems, thus providing golden opportunities for us to improve our healthcare delivery. In the
post- COVID19 era, the world is moving into a new way of delivering healthcare, and in this
lecture, we will also review the roles of teleconsultation and remote monitoring especially
in diabetes care, and future ways to empower the healthcare system to withstand future
natural or man-made catastrophes.

PAGE21